Botfet / Company detail

PTCT

universe

PTC Therapeutics, Inc.

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic33.4%

Gross Margin95.9%

Revenue Cagr33.9%

Fcf Conversion60.2%

Fcf Yield8.1%

Interest Coverage5.8x

Market Cap B$5.1B

PeNot available: not applicable loss making

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener